Recurrence in Bladder Cancer: A Molecular Dead End?
Journal:
Current Genomics
Volume:
4
Page:
417-434
Author(s):
John M. S. Bartlett, Joanne Edwards and Ken M. Grigor
Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
iv-iv
Author(s):
Steven Rosenberg
Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1483-1498
Author(s):
Todd W. Rockway and Vincent L. Giranda
Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1499-1528
Author(s):
Michael Ploug
Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1529-1543
Author(s):
Ute Reuning, Stefan Sperl, Charlotte Kopitz, Horst Kessler, Achim Kruger, Manfred Schmitt and Viktor Magdolen
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1545-1564
Author(s):
Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc and Daniel A. Lawrence
Urokinase Receptor and Integrin Interactions
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1565-1574
Author(s):
Matthias C. Kugler, Ying Wei and Harold A. Chapman
Low-Cost Anti-HIV Compounds: Potential Application for AIDS Therapy in Developing Countries
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1419-1431
Author(s):
Aldar S. Bourinbaiar and Vichai Jirathitikal
Preface [Hot Topic: Anticancer Agents: To Kill in a Good Cause (Guest Editor : Eric Solary)].
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
i-i
Author(s):
Eric Solary
Death Receptor Signaling in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
253-262
Author(s):
Simone Fulda and Klaus-Michael Debatin